Kestra Advisory Services’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,476
| Closed | -$12.2K | – | 2545 |
|
|
2023
Q4 | $12.2K | Sell |
16,476
-1,500
| -8% | -$1.11K | ﹤0.01% | 2254 |
|
|
2023
Q3 | $15.6K | Sell |
17,976
-7,507
| -29% | -$6.53K | ﹤0.01% | 2088 |
|
|
2023
Q2 | $47.7K | Sell |
25,483
-1
| -0% | -$2 | ﹤0.01% | 2052 |
|
|
2023
Q1 | $94.3K | Hold |
25,484
| – | – | ﹤0.01% | 1960 |
|
|
2022
Q4 | $96.9K | Hold |
25,484
| – | – | ﹤0.01% | 2142 |
|
|
2022
Q3 | $201K | Sell |
25,484
-50
| -0.2% | -$394 | ﹤0.01% | 1877 |
|
|
2022
Q2 | $536K | Buy |
+25,534
| New | +$536K | 0.01% | 1297 |
|